Chemodex

(±)-Propranolol hydrochloride

CHF 108.00
In stock
CDX-P0483-G02525 gCHF 108.00
CDX-P0483-G100100 gCHF 326.00
More Information
Product Details
Synonyms (±)-1-Isopropylamino-3-(1-naphthyloxy)-2-propanol hydrochloride; DL-Propranolol hydrochloride; ICI 45520; NSC 91523
Product Type Chemical
Properties
Formula

C16H21NO2 . HCl

MW 295.8
CAS 318-98-9
RTECS UB7525000
Purity Chemicals ≥99% (TLC)
Appearance White powder.
Solubility Soluble in DMSO (15mg/ml), ethanol (10mg/ml) or water (20mg/ml). Aqueous solutions are most stable at pH 3.0 and decompose rapidly at basic pH. Decomposition is accompanied by discoloration of the solution.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key ZMRUPTIKESYGQW-UHFFFAOYSA-N
Smiles OC(CNC(C)C)COC1=CC=CC2=CC=CC=C21.Cl
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +4°C
Handling Advice Keep under inert gas.
Very hygroscopic.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

(±)-Propranolol hydrochloride is a β-adrenergic receptor (β-AR) antagonist (Kds = 6.91, 0.832, and 117.49 nM for human β1-, β2- and β3-ARs, respectively). It also acts as a non-specific 5-HT1/5-HT2 serotonin receptor antagonist, reducing tranylcypromine/L-tryptophan-induced hyperactivity in rats. (±)-Propranolol hydrochloride is useful as an antihypertensive drug, cardiac depressant and also in the treatment of angina pectoris. It decreases the effect of stress and exercise on heart by reducing the rate of contraction and conduction of impulse. It is known to competitively block the action of catecholamines.

Product References

(1) J.D. Fitzgerald & S.R. O'Donnell; Br. J. Pharmacol. 45, 207 (1972) | (2) B. Basil, et al.; Br. J. Pharmacol. 50, 323 (1974) | (3) D.W. Costain & A.R. Green; Br. J. Pharmacol. 64, 193 (1978) | (4) S.E. Litwin, et al.; Br. J. Pharmacol. 127, 1671 (1999) | (5) J.G. Baker; Br. J. Pharmacol. 144, 317 (2005) | (6) M.J. Wagner, et al.; J. Exp. Pharmacol. 10, 51 (2018)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.